证券代码：300334 证券简称：津膜科技 公告编码：2023-064 天津膜天膜科技股份有限公司 第四届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、天津膜天膜科技股份有限公司（以下简称"公司"）第四届董事会第十九 次会议通知于 2023 年 8 月 15 日向各位董事以书面方式送达。 2、本次董事会于 2023 年 8 月 25 日以现场与通讯结合方式召开。现场会议地 点：天津经济技术开发区第十一大街 60 号会议室。 3、本次董事会会议应到董事 10 名，实到董事 10 名。（其中：以通讯表决方 式出席会议 9 名）。董事范宁先生、翟军先生、梁峰先生、郑春建先生、李东依先 生、郭有智先生、王春青先生、刘志刚先生、崔嵘女士以通讯方式参加会议并表 决。 三、备查文件 1、《天津膜天膜科技股份有限公司第四届董事会第十九次会议决议》。 特此公告。 4、董事长范宁先生作为本次会议的主持人，公司监事会成员施耀华先生、 陈豪先生、魏海英女士、总经理范宁先生、首席科学家吕晓龙先生、副总经理兼 财务总监于建华先生、 ...

证券代码：300334 证券简称：津膜科技 公告编码：2023-061 天津膜天膜科技股份有限公司 关于召开2023年第三次临时股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏 天津膜天膜科技股份有限公司（以下简称"公司"）于 2023 年 8 月 3 日召开的第 四届董事会第十八次会议审议通过了《关于提请召开 2023 年第三次临时股东大会的议 案》，公司董事会决定于 2023 年 8 月 21 日（星期一）召开 2023 年第三次临时股东大 会，现将本次股东大会有关事宜再次公告提示如下： 一．本次股东大会召开的基本情况 1.股东大会届次：2023年第三次临时股东大会 2．会议召集人：公司董事会 3.会议召开的合法性、合规性：经公司第四届董事会第十八次会议审议通过《关 于提请召开2023年第三次临时股东大会的议案》，公司决定于2023年8月21日召开本次 股东大会。本次股东大会召开程序符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 4.会议召开的日期和时间： （1）现场会议召开时间：2023年8月21日（星期一）下午1 ...

证券代码：300334 证券简称：津膜科技 公告编码：2023-058 天津膜天膜科技股份有限公司 天津膜天膜科技股份有限公司（以下简称 "公司"）监事会近日收到监事毕然女 士提交的书面辞职报告。毕然女士因个人原因申请辞去公司第四届监事会监事的职务 （原定任期至第四届监事会届满即 2025 年 1 月 12 日止）。辞职后， 毕然女士将不再担 任公司任何职务。毕然女士在任期内辞去监事职务将导致公司监事会成员低于法定人 数，因此毕然女士辞职申请将自公司股东大会选举产生新任监事填补其空缺后生效，在 此期间，毕然女士将继续履行其监事职责。 毕然女士在担任公司监事期间，未直接或间接持有公司股份，不存在应当履行而未 履行的承诺事项。 为使监事会成员尽快达到法定人数，保证公司监事会的正常运转，根据《中华人共 和国公司法》（以下简称"《公司法》"）、《公司章程》的有关规定，公司控股股东向董事 会提交了《关于提请增加天津膜天膜科技股份有限公司 2023 年度第三次临时股东大会 临时提案的函》。董事会将《关于补选公司非职工代表监事的议案》以临时提案方式提 交公司 2023 年第三次临时股东大会一并审议。根据《关于补选公司非职工 ...

证券代码：300334 证券简称：津膜科技 公告编码：2023-059 天津膜天膜科技股份有限公司 关于增加2023年第三次临时股东大会临时提案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 天津膜天膜科技股份有限公司（以下简称"公司"）于 2023 年 8 月 4 日在巨潮资讯 网（www.cninfo.com.cn）发布了《关于召开 2023 年第三次临时股东大会通知的公告》 （公告编号：2023-056），计划于 2023 年 8 月 21 日（星期一）下午 13:30 采用现场投 票和网络投票相结合的方式召开公司 2023 年第三次临时股东大会。 公司监事会于 2023 年 8 月 10 日收到监事会主席毕然女士的辞职信，毕然女士因 个人原因，辞去公司监事职务。同日，公司控股股东航膜科技发展集团有限公司（以 下简称"航膜科技"）向公司发出《关于提请增加天津膜天膜科技股份有限公司 2023 年 度第三次临时股东大会临时提案的函》，为使监事会成员尽快达到法定人数，保证公司 监事会的正常运转，将《关于补选公司非职工代表监事的议案》以临时提案方式提交 ...

天津膜天膜科技股份有限公司 关于2023年第三次临时股东大会增加临时提案暨股东大会补充 通知的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、 证券代码：300334 证券简称：津膜科技 公告编码：2023-060 完整，没有虚假记载、误导性陈述或重大遗漏 特别说明： 1、股东大会有关情况 天津膜天膜科技股份有限公司（以下简称"公司"）于 2023 年 8 月 4 日在巨潮资 讯网（www.cninfo.com.cn）披露了《关于召开 2023 年第三次临时股东大会通知的公 告》（公告编号：2023-056），定于 2023 年 8 月 21 日（星期一）下午 13:30 召开 2023 年第三次临时股东大会。 2、增加临时提案的情况说明 （1）增加临时提案的名称 | 提案编码 | 提案名称 | | --- | --- | | 3.00 | 《关于补选公司非职工代表监事的议案》 | （2）增加临时提案的程序及说明 2023 年 8 月 10 日，公司董事会收到持有公司股份 22.62%的股东航膜科技发展集 团有限公司提交的《关于提请增加天津膜天膜科技股份有限公司 2023 年度第三次临时 股东大会临 ...

证券代码：300334 证券简称：津膜科技 天津膜天膜科技股份有限公司投资者关系活动记录表 编号：2023-001 | 投资者关系活动 | □特定对象调研 □分析师会议 | | --- | --- | | 类别 | □媒体采访 业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 参与公司 2022 年度业绩网上说明会的投资者 | | 人员姓名 | | | 时间 | 2023 年 5 月 8 日 15:00-17:00 | | 地点 | 全景网"投资者关系互动平台"http://ir.p5w.net/ | | 上市公司接待人 | 董事长兼总经理 范宁 | | 员姓名 | 独立董事 王春青 | | | 副总经理/投融资总监/董事会秘书 宋辉鹏 | | | 副总经理/财务总监 于建华 | | | 公司于 2023 年 4 月 19 日发布关于举行 2022 年度业绩说明 会的公告（详见披露于巨潮资讯网的公告，公告编号： | | | 2023-033）。公司于 2023 年 5 月 8 日通过网络形式（全景网 | | ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥52,128,178.90, a decrease of 11.99% compared to ¥59,232,541.62 in the same period last year[5]. - The net profit attributable to shareholders was -¥1,770,821.60, an improvement of 86.31% from -¥12,931,999.87 year-on-year[5]. - The net cash flow from operating activities was -¥17,764,305.95, a significant decline of 640.09% compared to -¥2,400,291.82 in the previous year[5]. - The company's basic earnings per share improved by 86.21% to -¥0.0059 from -¥0.0428 year-on-year[5]. - The net profit for the first quarter of 2023 was -1,524,206.61 CNY, compared to -12,924,824.38 CNY in the same period last year, indicating a significant improvement[39]. - Operating profit for the current period was -1,324,034.79 CNY, an improvement from -9,109,017.73 CNY year-over-year[39]. - The total comprehensive income attributable to the parent company was -1,770,821.60 CNY, compared to -12,931,999.87 CNY in the previous year[39]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,114,585,246.01, down 27.38% from ¥1,534,759,509.42 at the end of the previous year[5]. - The company's total liabilities decreased to CNY 481,413,414.38 from CNY 877,497,856.53, indicating a reduction of about 45.0%[35]. - The total owner's equity as of March 31, 2023, was CNY 633,171,831.63, down from CNY 657,261,652.89, representing a decline of approximately 3.7%[35]. - The accounts receivable decreased to CNY 172,031,750.56 from CNY 260,335,700.34, indicating a reduction of approximately 33.9%[33]. - Inventory decreased to CNY 56,658,110.82 from CNY 67,690,083.65, reflecting a decline of about 16.4%[33]. Cash Flow and Investments - Cash and cash equivalents increased by 570.48% to ¥156,616,300.00, primarily due to the sale of equity in a subsidiary[9][10]. - The company's cash and cash equivalents increased to CNY 156,616,336.52 from CNY 23,358,876.11 at the beginning of the year, showing a significant increase[31]. - Investment activities generated a net cash inflow of 327,752,675.58 CNY, a significant increase compared to -1,265,924.52 CNY in the previous year[43]. - The company reported a cash and cash equivalents balance of 149,852,016.39 CNY at the end of the period, up from 31,462,390.80 CNY at the end of the previous year[43]. Expenses and Income - The total operating costs for the first quarter of 2023 were CNY 65,966,742.83, a decrease of 10.6% compared to CNY 73,743,792.43 in the previous year[36]. - The operating cost for the first quarter was CNY 38,056,479.16, down from CNY 46,785,050.44, reflecting a reduction of approximately 18.5%[36]. - Sales expenses decreased by 2.0085 million yuan, a year-on-year decline of 33.38%, mainly due to a reduction in service fees[17]. - Management expenses increased by 2.856 million yuan, a year-on-year increase of 42.05%, primarily due to service fee increases and prior period losses[17]. - The company incurred research and development expenses of 6,303,139.50 CNY, an increase from 4,893,011.62 CNY year-over-year[39]. - The company's financial expenses included interest expenses of 7,533,966.07 CNY, down from 9,366,232.32 CNY in the previous year[39]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,007[20]. - The largest shareholder, Hangmo Technology Development Group Co., Ltd., holds 21.19% of the shares, totaling 64,004,465 shares[20]. - High-tech Investment Development Co., Ltd. reduced its holdings by 1.7885 million shares, bringing its total holdings to 28.9617 million shares, representing 9.5879% of the total share capital[26]. Equity Transfers - The company completed the transfer of 69% equity in Dongying Jinmo Environmental Technology Co., Ltd. and 100% equity in Dongying Membrane Tian Environmental Technology Co., Ltd. to a consortium led by Chengdu Xingrong Environment Co., Ltd. and Shanghai Diyu Technology Co., Ltd. on February 24, 2023[29]. - Investment income increased by 10.8671 million yuan, a year-on-year increase of 4554.55%, mainly due to the transfer of equity in Dongying subsidiary[17]. - The company reported a significant increase in investment income of 4554.55%, reaching ¥1,110,570.00 compared to ¥23,860.00 in the previous year[16].

Financial Performance - The company's operating revenue for 2022 was ¥244,813,144.24, a decrease of 48.28% compared to ¥473,336,155.34 in 2021[23]. - The net profit attributable to shareholders for 2022 was -¥184,656,511.85, representing a decline of 752.60% from ¥28,295,675.93 in 2021[23]. - The net cash flow from operating activities was ¥4,374,452.23, down 93.83% from ¥70,856,510.64 in the previous year[23]. - The total assets at the end of 2022 were ¥1,534,759,509.42, a decrease of 3.17% from ¥1,585,013,039.67 at the end of 2021[23]. - The company's net assets attributable to shareholders decreased by 23.74% to ¥587,546,315.46 from ¥770,486,831.33 in 2021[23]. - The basic earnings per share for 2022 was -¥0.61, a decline of 777.78% compared to ¥0.09 in 2021[23]. - The weighted average return on equity was -27.19% in 2022, down 30.93% from 3.74% in 2021[23]. - The company reported a total of ¥4,053,714.32 in non-recurring gains and losses for 2022, compared to ¥22,326,810.29 in 2021[30]. - The company's financial expenses increased by 42.54% in 2022, amounting to ¥43,188,687.42, primarily due to increased shareholder loans and subsidiary interest expenses[66]. Operational Challenges - The company's performance declined due to external environmental fluctuations, resulting in decreased production line operating rates and delivery delays[4]. - Major raw material prices increased significantly, leading to a decrease in membrane product gross profit by RMB 23.04 million compared to the same period last year[4]. - The gross profit from membrane engineering decreased by RMB 78.83 million year-on-year due to reduced new and ongoing engineering projects and provisions for litigation liabilities[4]. - Credit impairment losses increased by RMB 43.56 million, primarily due to provisions for overdue accounts receivable[4]. - Asset impairment losses rose by RMB 15.88 million, mainly from provisions for engineering project asset impairments[4]. - Other income decreased by RMB 7.01 million due to lower amortization of government subsidies for research projects[5]. - The company faced significant challenges due to external economic fluctuations, resulting in production line downtime and increased raw material costs[51]. Strategic Focus and Future Plans - The company plans to maintain its focus on membrane products and technology services, aiming to enhance revenue and performance as external conditions improve in 2023[5]. - The company aims to achieve a national environmental equipment manufacturing industry output value of 1.3 trillion yuan by 2025, focusing on membrane technology as a key direction[36]. - The company is involved in providing wastewater treatment operation and technical services, primarily to government agencies and municipal units[45]. - The company is exploring opportunities for mergers and acquisitions to strengthen its market position[57]. - The company aims to improve its market share by enhancing product quality and developing innovative membrane technologies[69]. - The company plans to invest in new product and process development, technology upgrades, and market expansion in 2023, leveraging cash flow and financing[100]. Research and Development - The company has made significant breakthroughs in membrane material improvement, product research and development, and application of membrane technology processes during the reporting period[47]. - The company applied for 17 patents, with 6 patents granted, and received multiple national-level research project completions[47]. - The company is focused on enhancing its technological capabilities through research and development initiatives[57]. - In 2022, the company's R&D investment amounted to ¥24,089,784.21, representing 9.84% of operating revenue, an increase from 5.93% in 2021[71]. - The company has developed a new low-cost, high-performance PVDF modified membrane with independent intellectual property rights, significantly reducing investment and operating costs for membrane separation applications[69]. Governance and Management - The company is committed to maintaining a governance structure that complies with relevant laws and regulations to ensure transparency and protect shareholder interests[112]. - The company established a performance evaluation and incentive mechanism for senior management, aligning with its development status[119]. - The company reported a change in senior management, with the resignation of key personnel including the chief scientist and deputy general manager[126]. - The company has a significant focus on R&D, with a new Chief Scientist appointed to enhance technological advancements[128]. - The company is committed to maintaining a strong leadership structure to support its growth and market expansion strategies[128]. Environmental Compliance - The company achieved a COD discharge concentration of 21.6 mg/L, significantly below the regulatory limit of 50 mg/L, with a total COD discharge of 1,033 tons[183]. - The company reported a total nitrogen (TN) discharge of 10.6 mg/L, which is also below the regulatory limit of 15 mg/L, with a total TN discharge of 518 tons[183]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[189]. - The company has committed to increasing the use of renewable energy by replacing traditional lighting with solar-powered LED lights[189]. - The company has established emergency response plans for environmental incidents, which have been filed with local environmental authorities[185].

天津膜天膜科技股份有限公司（以下简称"公司"）已于2023年4月19日发 布了《2022年年度报告及摘要》。为便于广大投资者更深入全面地了解公司情况， 公司定于2023年5月8日（星期一）下午15:00-17:00举行2022年度网上业绩说明 会，现将有关事项通知如下：本次2022年度网上业绩说明会将采用网络远程的方 式举行，投资者可登陆"全景路演天下"（http://rs.p5w.net）参与本次业绩 说明会。出席本次年度报告说明会的人员有：公司董事长兼总经理范宁先生、副 总经理/投融资总监/董事会秘书宋辉鹏先生、副总经理/财务总监于建华先生、 独立董事王春青先生。 为提高交流效率，公司现提前向投资者征集相关问题，广泛听取投资者的意 见和建议。投资者可于2023年5月7日（星期日）17:00 时前将有关问题通过电子 邮件的形式发送至公司投资者关系邮箱（ir@motimo.com.cn）。欢迎广大投资者 积极参与！ 证券代码：300334 证券简称：津膜科技 公告编码：2023-033 天津膜天膜科技股份有限公司 关于举行2022年度网上业绩说明会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完 ...